IRONWOOD PHARMACEUTICALS INC IRWD

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $3.97
Market Cap $653.52M
P/E Ratio 26.47
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-15.7% YoY
$296.15M
3-Yr CAGR: -10.3%
Net Income ↑2,629.2% YoY
$24.02M
Net Margin: 8.1%
Free Cash Flow ↑22.8% YoY
$127.01M
FCF Yield: 19.43%
EPS (Diluted) ↑1,400.0% YoY
$0.15
Basic: $0.15
Return on Equity Efficiency
N/A
ROA: 6.1%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (IRWD)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $274.0M $234.8M $-81.7M 0.00% $-25.4M $-29.6M
FY 2017 $298.3M +8.9% $261.9M $-116.9M -43.1% 0.00% $-99.6M $-103.8M -250.1%
FY 2018 $346.6M +16.2% $308.9M $-282.4M -141.5% 0.00% $-70.9M $-79.5M +23.4%
FY 2019 $428.4M +23.6% $391.8M $21.5M +107.6% $0.14 0.00% $10.7M $3.5M +104.4%
FY 2020 $389.5M -9.1% $360.0M $106.2M +393.7% $0.66 +371.4% 0.00% $168.8M $167.0M +4,622.7%
FY 2021 $413.8M +6.2% $343.4M $528.4M +397.7% $3.21 +386.4% 0.00% $261.9M $261.6M +56.7%
FY 2022 $410.6M -0.8% $366.3M $175.1M -66.9% $0.96 -70.1% 0.00% $273.8M $273.6M +4.6%
FY 2023 $442.7M +7.8% $-787.1M $-1,002.2M -672.5% $-6.45 -771.9% 0.00% $183.4M $183.2M -33.1%
FY 2024 $351.4M -20.6% $237.4M $0.9M +100.1% $0.01 +100.2% 0.00% $103.5M $103.4M -43.5%
FY 2025 $296.2M -15.7% $180.8M $24.0M +2,629.2% $0.15 +1,400.0% 0.00% $127.0M $127.0M +22.8%
$

Valuation

Market Price $3.97
Market Cap $653.52M
Enterprise Value $438.06M
P/E Ratio 26.47
P/B Ratio N/A
FCF Yield 19.43%
Dividend Yield N/A
Shares Outstanding 164,613,400
%

Profitability & Margins

Gross Margin 61.04%
Operating Margin 33.26%
Net Margin 8.11%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) 6.05%
Asset Turnover 0.75x
Revenue 3-Yr CAGR -10.32%
🛡️

Financial Health & Liquidity

Current Ratio 1.13
Cash Ratio 0.89
Debt / Equity -0.000
Debt / Assets 0.000
Cash & Equivalents $215.46M
Total Debt N/A
Book Value / Share $-1.59
💧

Cash Flow Efficiency

Operating Cash Flow $127.04M
Capital Expenditures (CapEx) $34.00K
Free Cash Flow $127.01M
OCF / Revenue 42.90%
FCF / Revenue 42.89%
FCF 3-Yr CAGR -22.57%
🏷️

Per Share Metrics

EPS (Diluted) $0.15
EPS (Basic) $0.15
Dividends / Share N/A
Book Value / Share $-1.59
EPS YoY Growth 1,400.00%
🏛️

Balance Sheet (FY 2025)

Total Assets $396.90M
Total Liabilities $658.74M
Stockholders' Equity -$261.83M
Current Assets $274.18M
Current Liabilities $242.22M